Research suggests that abnormal cortisol levels might serve as a prognostic indicator in certain types of cancer. Elevated cortisol levels have been associated with poorer outcomes in patients with breast cancer, lung cancer, and other malignancies. Monitoring cortisol levels could potentially help in assessing the progression of the disease and tailoring more effective treatment strategies.
